TITLE

P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells

AUTHOR(S)
Qiu, Ying; Li, Wei-hua; Zhang, Hong-quan; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang
PUB. DATE
December 2014
SOURCE
PLoS ONE;Dec2014, Vol. 9 Issue 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The ATP-gated P2X7 has been shown to play an important role in invasiveness and metastasis of some tumors. However, the possible links and underlying mechanisms between P2X7 and prostate cancer have not been elucidated. Here, we demonstrated that P2X7 was highly expressed in some prostate cancer cells. Down-regulation of P2X7 by siRNA significantly attenuated ATP- or BzATP-driven migration and invasion of prostate cancer cells in vitro, and inhibited tumor invasiveness and metastases in nude mice. In addition, silencing of P2X7 remarkably attenuated ATP- or BzATP- driven expression changes of EMT/invasion-related genes Snail, E-cadherin, Claudin-1, IL-8 and MMP-3, and weakened the phosphorylation of PI3K/AKT and ERK1/2 in vitro. Similar effects were observed in nude mice. These data indicate that P2X7 stimulates cell invasion and metastasis in prostate cancer cells via some EMT/invasion-related genes, as well as PI3K/AKT and ERK1/2 signaling pathways. P2X7 could be a promising therapeutic target for prostate cancer.
ACCESSION #
100186507

 

Related Articles

  • Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis. Donald Wong; Kandagatla, Pridvi; Korz, Walter; Chinni, Sreenivasa R. // BMC Urology;2014, Vol. 14 Issue 1, p1 

    Background CXCL12/CXCR4 transactivation of epidermal growth factor family receptors in lipid raft membrane microdomains on cell surface is thought to mediate tumor growth and subsequent development of metastatic disease. CTCE-9908 is a known inhibitor of CXCR4. Herein, we tested the efficacy of...

  • Translational Profiling Suggests How to Judge, Use Cancer Drug. Breindl, Anette // BioWorld Today;2/24/2012, Vol. 23 Issue 37, p1 

    The article focuses on a study published in the February 23, 2012 issue of "Nature" which examined protein translation in prostate cancer metastasis. Allosteric and adenosine triphosphate-site inhibitors were used to profile cancer cell lines and analyze the effects of treatment on them. Results...

  • Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression. Longoni, N; Kunderfranco, P; Pellini, S; Albino, D; Mello-Grand, M; Pinton, S; D'Ambrosio, G; Sarti, M; Sessa, F; Chiorino, G; Catapano, C V; Carbone, G M // Oncogene;5/2/2013, Vol. 32 Issue 18, p2315 

    By integrating gene profiling and immunohistochemical data with functional experiments in cell lines in this study we show for the first time that doublecortin (DCX) domain containing 2 (DCDC2), a protein belonging to the DCX family and involved in neuronal cell migration, is aberrantly...

  • E17K substitution in AKT1 in prostate cancer. Boormans, J. L.; Korsten, H.; Ziel-van der Made, A. C. J.; van Leenders, G. J. L. H.; Verhagen, P. C. M. S.; Trapman, J. // British Journal of Cancer;5/11/2010, Vol. 102 Issue 10, p1491 

    Background:The phosphatidylinositol 3-kinase (PI3K)–AKT pathway is activated in many cancers. Mutational hotspots in AKT1 and in the regulatory and catalytic subunits of PI3K have been detected in multiple tumour types. In AKT1, the E17K substitution leads to a PI3K-independent activation...

  • Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. Banyard, Jacqueline; Chung, Ivy; Migliozzi, Matthew; Phan, Derek T.; Wilson, Arianne M.; Zetter, Bruce R.; Bielenberg, Diane R. // BMC Cancer;2014, Vol. 14 Issue 1, p1075 

    Background Understanding the complex, multistep process of metastasis remains a major challenge in cancer research. Metastasis models can reveal insights in tumor development and progression and provide tools to test new intervention strategies. Methods To develop a new cancer metastasis model,...

  • IGF-IR Promotes Prostate Cancer Growth by Stabilizing α5β1 Integrin Protein Levels. Sayeed, Aejaz; Fedele, Carmine; Trerotola, Marco; Ganguly, Kirat K.; Languino, Lucia R. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Dynamic crosstalk between growth factor receptors, cell adhesion molecules and extracellular matrix is essential for cancer cell migration and invasion. Integrins are transmembrane receptors that bind extracellular matrix proteins and enable cell adhesion and cytoskeletal organization. They also...

  • A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer. Pértega-Gomes, Nelma; Vizcaíno, José R.; Attig, Jan; Jurmeister, Sarah; Lopes, Carlos; Baltazar, Fátima // BMC Cancer;2014, Vol. 14 Issue 1, p349 

    Background In a malignant tumour, cancer cells are embedded in stromal cells, namely cancer-associated fibroblasts (CAFs). These CAFs are now accepted as important players in cancer dynamics, being involved in tumour growth and progression. Although there are various reports on the interaction...

  • Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. Sluis, Tim; Bijnsdorp, Irene; Jacobs, John; Meuleman, Eric; Rozendaal, Lawrence; Geldof, Albert; Moorselaar, R.; Vis, André // World Journal of Urology;Apr2013, Vol. 31 Issue 2, p261 

    Purpose: Prostate cells are dependent on androgens for growth and proliferation. Androgen deprivation therapy is the recommended treatment for advanced/metastatic prostate cancer. Under this therapy, prostate cancer will inevitably progress to castration resistant prostate cancer (CRPC). Despite...

  • The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target. Paccez, J D; Vasques, G J; Correa, R G; Vasconcellos, J F; Duncan, K; Gu, X; Bhasin, M; Libermann, T A; Zerbini, L F // Oncogene;2/7/2013, Vol. 32 Issue 6, p689 

    Deregulation of the receptor tyrosine kinase Axl has been implicated in the progression of several human cancers. However, the role of Axl in prostate cancer remains poorly understood, and the therapeutic efficacy of Axl targeting remains untested. In this report we identified Axl as a new...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics